¼ºÀÎALL¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö : 2022-11-26±³À°ÀÏÀÚ : 2022-11-26
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï ÄÚ¿¢½º Allegro & Andante Room
±³À°ÁÖÁ¦ :
¼ºÀÎALL¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼ºÀÎALL¿¬±¸È¸
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-26 Allegro & Andante Room 10:00~10:40 Measurable Residual Disease by Next-Generation Flow Cytometry in B-ALL (acute lymphoblastic leukemia) ¾È¾Æ¸®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-26 Allegro & Andante Room 10:40~11:20 Diagnostic algorithms in BCR-ABL1-like (Philadelphia-like) B-ALL (acute lymphoblastic leukemia ) ¹ÚÁÖÇå(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-26 Allegro & Andante Room 11:20~12:00 Treatment of Philadelphia negative ALL(acute lymphoblastic leukemia) ÀÌÀ¯Áø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-26 Allegro & Andante Room 12:00~12:30 Treatment of Philadelphia positive ALL (acute lymphoblastic leukemia) °°¡¿ø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-26 Allegro & Andante Room 12:30~13:00 Roll of Transplantation in the cell therapy era ¹éµ¿¿ø(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-26 Allegro & Andante Room 14:00~14:40 Recent advances in novel antibody therapy ÀÌÁöÇö(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 11-26 Allegro & Andante Room 14:40~15:20 CAR-T & cellular immunotherapy À±ÀçÈ£(°¡Å縯ÀÇ´ë)